Results 171 to 180 of about 77,862 (256)

A Meta-Analysis of Anti-Thyroid Peroxidase Antibody and Omalizumab Response in Chronic Spontaneous Urticaria. [PDF]

Clin Exp Allergy
Lee JH, Geum MJ, Kim DY, Ah YM, Yu YM.
europepmc   +1 more source

Biosimilars in chronic spontaneous urticaria: current evidence, clinical implications and future perspectives [PDF]

Alessandro Sinisi, Eustachio Nettis, Corrado D’Andria, Mattia Cristallo, Giorgio Walter Canonica   +4 more
openalex   +1 more source

Review on the Application of Biologic Factors in Atopic Dermatitis and Chronic Spontaneous Urticaria. [PDF]

Dermatol Res Pract
Salavoura A.
europepmc   +1 more source

Real-world treatment patterns and healthcare utilization following omalizumab initiation in chronic spontaneous urticaria: a nationwide Brazilian cohort study [PDF]

José Arnaldo Shiomi da Cruz, Breno Cordeiro Porto, Janniele Carla Malaquias de Lima, Tamara Goldenstein Schainberg, Luiz Rodolfo Egydio de Cerqueira Cesar, Carlos Augusto Lima de Campos, Victor Hugo Ovani Marchetti, Rodrigo Afonso da Silva Sardenberg   +7 more
openalex   +1 more source

Correction: Corticosteroid-Associated Adverse Events in Chronic Spontaneous Urticaria: A US Claims Data Study. [PDF]

Dermatol Ther (Heidelb)
Yosipovitch G, Patil D, Rodrigues J, Kuruvilla M, Raftery T, Pivneva I, Doran J, Voegel A, Signorovitch J, Riedl MA.   +9 more
europepmc   +1 more source

Remibrutinib in inadequately controlled chronic spontaneous urticaria after switching from omalizumab: a real-world case series

Yu-ting Zhang
openalex   +1 more source

Murine Model of Chronic Spontaneous Urticaria-Like Skin. [PDF]

Allergy
He Y, Ye D, Guo J, Zeng W, Wang Z.
europepmc   +1 more source

Targeting immune dysregulation in chronic spontaneous urticaria: beyond antihistamines. [PDF]

Korean J Intern Med
Ye YM.
europepmc   +1 more source

Dupilumab in Difficult-to-treat Chronic Spontaneous Urticaria: A Real-world Multicentre Cohort Study. [PDF]

Acta Derm Venereol
Planella-Fontanillas N, Berna-Rico E, Figueras-Nart I, Spertino J, Dols Casanova L, Gatica Ortega ME, Expósito-Serrano V, Lasheras Pérez MA, Rodríguez Serna M, Mascaró JM, Melé-Ninot G, Mercader-García P, Navarro Triviño FJ, Tous Romero F, Elosua-González M, Magdaleno-Tapial J, Pérez Ferriols A, Montero-Vilchez T, Torné Gutiérrez JI, Gallardo F, Pesqué D, Pujol RM, Serra-Baldrich E, Giménez-Arnau AM.   +23 more
europepmc   +1 more source

Omalizumab to dupilumab switch in chronic spontaneous urticaria. [PDF]

World Allergy Organ J
Özdemir Ö.
europepmc   +1 more source